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Introduction 90 91
Conventional IVF, or the generation of embryos and pregnancies following ovarian 92 hyperstimulation, has proven a great medical advance. Yet the technology remains inefficient, 93 with only an 18% success rate (live birth/initiated IVF cycle; (Macaldowie et al., 2014) ), it is 94 expensive and ovarian hyperstimulation is not without significant health risks (Market-Velker 95 et al., 2010; Seggers et al., 2014) . Oocyte in vitro maturation (IVM) is a related useful 96 technique to generate mature oocytes and embryos for clinical infertility treatment but uses 97 minimal or no ovarian hyperstimulation (Edwards 1965) . Clinical application of IVM has 98 remained limited due to lower embryo yield and subsequent pregnancy rates compared to 99 conventional IVF (Nagai 2001; Gremeau et al., 2012) , although recent improvements in 100 pregnancy rates are providing significant promise (Ortega-Hrepich et al., 2013; Walls et al., 101 2015) . IVM is particularly attractive to patients who suffer from polycystic ovary syndrome as 102 these patients have a high antral follicle count and are at risk of developing ovarian 103 hyperstimulation syndrome during conventional IVF. Furthermore, with ever increasing cancer 104 survival rates, IVM has an important place in modern fertility preservation approaches, using 105 oocytes collected either from in vivo or ex vivo ovaries (Smitz et al., 2011) . In recent years, 106 improvement has been made in the efficacy of IVM in animals and translating these advances 107 to human IVM stands to bring significant benefits to health care providers and to patients 108 (Gilchrist et al., 2011). 109 110 It is widely accepted that the low efficiencies of IVM are in part due to precocious oocyte 111 meiotic resumption following artificial removal of cumulus-oocyte complexes (COCs) from 112 antral follicles and subsequent culture . We and others have 113 demonstrated that a temporary inhibition of spontaneous meiotic resumption, achieved by 114 preventing a fall in intra-oocyte cyclic adenosine monophosphate (cAMP) level through the 115 use of cAMP modulators prior to maturation (pre-IVM), better recapitulates some of the oocyte 116 maturation processes that occur in vivo, leading to greater oocyte developmental competence 117 (Luciano et al., 1999; Guixue et al., 2001; Shu et al., 2008; Albuz et al., 2010; Rose et al., 118 2013; Zeng et al., 2013; Franciosi et al., 2014; Richani et al., 2014; Zeng et al., 2014) . There 119 6 are several options to prevent the reduction in cAMP during this pre-IVM period, including the 120 use of specific and non-specific phosphodiesterase (PDE) inhibitors or dibutyryl-cAMP 121 (Funahashi et al., 1997; Gilchrist 2011) . We have previously shown that using the 122 non-specific PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX), in conjunction with increasing 123 cAMP synthesis in COCs with the adenylate cyclase activator, FSK, significantly improves 124 oocyte developmental competence as measured by blastocyst development rates and 125 post-transfer fetal yield (Albuz et al., 2010; Zeng et al., 2013; Richani et al., 2014; Zeng et al., 126 2014) . The application of cAMP-modulated IVM is now at the pre-clinical stage in human 127 assisted reproductive technology (ART) (Spits et al., 2015) . Moreover, in the mouse, 128 blastocyst yield and quality was greater when the pre-IVM period was lengthened beyond 1 129 hour (Richani et al., 2014) and 20 hours of dibutyryl-cAMP treatment is routinely used in 130 porcine IVM (Funahashi et al., 1997) , suggesting that the duration of cAMP-modulated 131 pre-IVM has important effects on oocyte developmental competence. 132 133 Treatment of COCs with cAMP modulators prolongs cumulus-oocyte gap junctional 134 communication (GJC) during IVM Shu et al., 2008; Luciano et al., 2011; 135 Franciosi et al., 2014) . Bidirectional crosstalk between the oocyte and cumulus cells (CCs) 136 are essential for oocyte growth, for enabling nutrients and other small molecules to transfer 137 between them, together ensuring that the oocyte acquires the molecular machinery required 138 to support early embryo development (Zuccotti et al., 1998; Albertini et al., 2001; Gilchrist et 139 al., 2004) . One such factor exchanged between CCs and the oocyte is reduced glutathione 140 (GSH). CC-oocyte GJC has been reported to regulate intra-oocyte GSH synthesis and 141 accumulation (de Matos et al., 1997; Nagai 2001; de Matos et al., 2002) . GSH plays important 142 roles as a reducing agent (and therefore an antioxidant) in oocyte maturation, fertilization and 143 embryonic development (Curnow et al., 2008; Takeo et al., 2015) . We hypothesize that one 144 mechanism by which pre-IVM with cAMP modulators improves oocyte competence is to 145 facilitate CC transfer and accumulation of GSH within the oocyte during the pre-IVM period. 146 Furthermore, we assessed if intra-oocyte GSH levels are increased by extending the duration 147 of cAMP-mediated pre-IVM (2, 4, 6 h). We undertook these experiments using bovine oocytes 148 as it has proven a valuable experimental model to understand the complexities of human 
COC collection 155
Bovine COCs were obtained from abattoir-derived ovaries of primarily cycling animals (but of 156 different breeds and fecundity) and transported to the laboratory at 35-37°C within 5 h of 157 collection. COCs were aspirated using an 18-gauge needle and a 10-ml syringe from 3-8 mm 158 diameter follicles of mixed growth and atresia status (Sirois and Fortune 1988) , and retained 159 in follicular fluid until transferred into pre-IVM medium (Albuz et al., 2010) . 160
161

COC in vitro maturation 162
Oocytes were matured in vitro using the simulated physiological oocyte maturation (SPOM) 163 version 2 system (Zeng et al., 2014; Gilchrist et al., 2015) . Differing duration of pre-IVM (0, 2, 164 4, 6 h) was a central variable examined in most experiments. Accordingly, the ensuing IVM 165 interval was either, 1) varied in some experiments to give a constant total time in vitro, or 2) 166 kept constant such that total time in vitro was extended. 167
pre-IVM 168
Depending on the experimental design, immature COCs were removed from aspirated 169 follicular fluid, washed three times and cultured in Vitromat (IVF Vet Solutions, Adelaide, 170 Australia) containing 4 mg/ml fatty acid-free bovine serum albumin (BSA; ICPbio Ltd, 171 Auckland, NZ), with or without 100 μM FSK (Sigma) and 500 μM IBMX (Sigma), during 172 pre-IVM periods (0, 2, 4 or 6 h). Millimolar stock concentrations of the cAMP modulators were 173 stored at -20°C dissolved in anhydrous dimethylsulphoxide (Sigma) solutions and were 174 diluted fresh for each experiment. 175
IVM 176
Following the pre-IVM treatments, bovine COCs were washed three times before maturation 177 in Vitromat + 4 mg/ml BSA + 50 μg/ml gentamycin (Sigma) + 100 mIU/ml recombinant human 178 FSH (Puregon, Organon) for 14 -24 h, depending on experimental design. Each replicate 8 included thirty to forty COCs per treatment and were cultured in pre-equilibrated 500 μl drops 180 overlaid with paraffin oil (Sigma) and incubated at 38.5°C with 6% CO2 in humidified air for the 181 time intervals indicated. 182 183
Assessment of oocytes 184
Oocytes were stained using the orcein staining methods, as described and validated 185 previously (Prentice-Biensch et al., 2012) , for the assessment of oocyte nuclear maturation. 186
Briefly, oocytes were stripped of CCs, mounted onto a glass slide and overlaid with a wax 187 supported coverslip. Denuded oocytes were fixed in ethanol: acetic acid (3:1, v/v) by using 188 capillary action to run the solution between the slide and coverslip, then stored at 4°C for 24 h. 189
Oocytes were stained with 1% orcein (w/v) in 45% acetic acid (v/v) for 20 min by the same 190 process and then cleared with a mix of 20% glycerol and 20% acetic acid in water. 191 Chromosomal configurations were evaluated using phase-contrast microscopy (Olympus; 192 Tokyo, Japan) and the stages of meiosis recorded. 193 194 Intra-oocyte GSH content was measured as described previously (Keelan et al., 2001) using 195 monochlorobimane (MCB, Sigma), a probe which reacts with reduced thiol groups (-SH) to 196 form fluorescence adducts. As MCB has the highest affinity for GSH, 99% of positive 197 fluorescence is attributed to binding with GSH (Keelan et al., 2001) . COCs were cultured 198 intact for variable intervals depending on the treatment, oocytes were denuded of CCs and 199 then incubated in wash medium (Vitrowash, IVF Vet Solutions) containing 12.5 μM MCB at 200 39°C in darkness for 30 mins. Oocytes were washed twice in wash medium and transferred to 201 5 μl of wash medium overlaid with paraffin oil in a glass bottom confocal dish (Cell E&G; 202 Houston, TX, USA). Oocytes were examined by using an Olympus Fluoview FV10i confocal 203 microscope (Olympus; Tokyo, Japan) with an excitation wavelength of 358 nm and emission 204 461 nm. Relative differences in GSH content, represented by the MCB-GSH fluorescence, 205 were determined using ImageJ software 1.33u (National Institutes of Health, Bethesda, MD, 206 USA) and normalized to the mean value of the background (excluding oocytes) in each image. 207
Microscope laser settings were standardized using Inspeck green fluorescence beads 208 (Molecular Probes, Eugene, OR, USA). Intra-oocyte H2O2 levels were measured by peroxyfluor-1 (PF-1), a specific fluorophore for 211 H2O2 (with some cross-reactivity with ONOO -, as previously described (Purdey et al., 2015) . 212
In brief, following denuding, oocytes were transferred to wash medium containing 100 μM 213 PF-1 at 39°C in darkness. After 30 min incubation, oocytes were washed once in VitroWash, 214 and oocytes transferred into 5 μl of wash medium overlaid with paraffin oil in a glass bottom 215 confocal dish. Fluorescence intensity was determined by confocal microscopy (excitation: 488 216 nm, emission: 520 nm) using the same procedure as described above. 217 218
Assessment of CC-oocyte GJC 219
Assessment of GJC between CCs and the oocyte during pre-IVM or IVM was determined by 220 lucifer yellow (LY; Sigma) dye transfer following microinjection of dye into the ooplasm of 221 intact COCs, as previously described (Luciano et al., 2004) . Briefly, a 3% w/v LY solution in 5 222 mM lithium chloride was injected into the oocyte. If CC-oocyte gap junctions are open then the 223 dye is free to diffuse into the CCs which can be observed and scored, whereas no dye 224 transfer occurs if GJC has ceased. The transfer of dye to surrounding CCs was assessed by 225 confocal microscope within 15 min of injection. Using a qualitative scoring system a 226 semi-quantitative GJC index can be calculated (Sugimura et al., 2014) . In brief, CC LY levels 227 were scored as +2 when the dye was transferred to the entire cumulus layer; +1 when the dye 228 was transferred to limited number of CC layers (primarily the corona radiate); and 0 when 229 there was minimal to no dye transfer into any CCs. 230
231
In vitro embryo production and differential staining 232
In vitro embryo production followed methods previously described (Hussein et al., 2006) . In 233 brief, following IVM, COCs were washed twice in wash medium and co-cultured with motile 234 sperm from a single bull of proven fertility (prepared using a discontinuous Percoll gradient, 235 GE Healthcare) in 500 μl of pre-equilibrated IVF medium (VitroFert, IVF Vet Solutions, + 4 236 mg/ml BSA + 10 IU/ml heparin), at a final concentration of 1 × 10 6 /ml frozen-thawed sperm 237 and cultured at 38.5°C in 6% CO2 in humidified air. After 22 h from the addition of sperm (day 238 1), presumptive zygotes were denuded of CCs by gentle pipetting and cultured in groups of 239 10 5-10 in 20 μl drops of VitroCleave (IVF Vet Solutions) + 4 mg/ml BSA, overlaid with paraffin oil 240 at 38.5°C in 7% O2, 6% CO2, N2 balance. On day 5, 5-10 embryos were transferred into 20 μl 241 of VitroBlast (IVF Vet Solutions) + 4 mg/ml BSA, overlaid with paraffin and cultured at 38.5°C 242 in 7% O2, 6% CO2, N2 balance. The rates of early and final cleavage embryo development 243
were assessed at 22 h on day 1 and day 5, respectively. Blinded embryo assessments, 244 including yield of blastocysts and hatched blastocysts, were performed on day 8. On day 8 245 post IVF, blastocysts in each group were processed using a differential staining protocol to 246 determine inner cell mass (ICM) and trophectoderm (TE) cell numbers, as previously 247 described (Hussein et al., 2006) . Differential staining was performed as ICM cell numbers 248 provide a robust measure of blastocyst quality, implantation and fetal developmental potential 249 (Lane and Gardner 1997; Sudiman et al., 2014) . The zona pellucida was removed by 250 incubation in 0.5% pronase in Dulbecco's phosphate-buffered saline (PBS) at 39°C. Embryos 251 were washed in protein-free PBS and incubated in 10% 2,4,6-trinitrobenzene sulfonic acid in 252 PBS for 10 min at 4°C in the dark; 10 mins in anti-2,4-dinitrophenol (1:10 w/v) at 39°C, 253 followed by 10 mins in complement (2 μg/ml solution of propidium iodide: guinea pig serum, 254 1:1). Embryos were transferred to (97%) ethanol containing 25 μg/ml of Hoechst 33342 255 (bisbenzimide) at 4°C for overnight staining. Embryos were mounted on microscope slides in 256 100% glycerol and the number of ICM and TE cells was determined using an epifluoresence 257 microscope (excitation = 340-380 nm and emission = 440-480 nm), whereby nuclei appeared 258 blue and pink, respectively. 259 260
Statistical analysis 261
Number of COCs per treatment and data set replicate numbers are provided in the figure 262 legends for each experiment. Proportional data for embryo development were arcsine 263 transformed before statistical analyses. Treatment effects were assessed by one-way or 264 two-way ANOVA followed by Turkey's multiple-comparison post-hoc test to identify individual 265 differences between means, using Prism 5.00 GraphPad for Windows (GraphPad Software, 266 San Diego, CA, USA). Two sample t-tests were used where only two sample means were 267 compared. Statistical significance was taken as P < 0.05. (Figure 2A ). An increase 286 in the yield of early cleaved embryos at 22h post-IVF was observed with 4 h and 6 h pre-IVM 287 periods compared with no pre-IVM (P<0.05; Figure 2B ), demonstrating that prolonging 288 pre-IVM duration accelerates 2-cell embryo development, which is a strong predictor of 289 pregnancy success (Sugimura et al., 2012) . Although final cleavage rates (as assessed on 290 day 5) were not significantly different between groups ( Figure 2C ), all pre-IVM treatments 291 increased the proportion of day 8 blastocysts/total embryos cleaved compared to no pre-IVM 292 (P<0.05; Figure 2D ). Hence, the final blastocyst yields (proportion of blastocysts/immature 293 oocyte) were 26.3% for the control, compared to 39.2%, 35.2% and 34.2%, for the 2 h, 4 h 294 and 6 h pre-IVM treatments, respectively. Only the 6 h pre-IVM period treatment yielded 295 significantly more hatched blastocysts than no pre-IVM treatment (P<0.05; Figure 2E ). 296 Importantly, all the pre-IVM treatments improved blastocyst quality, reflected by an increase in 297 total number of cells compared with no pre-IVM, made up largely by an increased ICM cell 298 number ( Figure 2F ; P<0.05), and notably, the 6 h pre-IVM treatment yielded the highest ratio 12 of ICM to total cells among all treatments, and was significantly different to that of no pre-IVM 300 (P<0.05; Figure 2F Figure 3C ). As shown in Figure 3B , during pre-IVM, GJC in the control group (no cAMP 307 modulators) fell sharply and progressively until 6 h of culture. On the contrary, the GJC 308 remained high for up to 6 h of culture in all pre-IVM groups in the presence of FSK and IBMX. 309 With regards to the combination of pre-IVM and IVM, during the first 8 hours of the IVM phase, 310 GJC remained significantly (P<0.05) higher than control (no pre-IVM) when COCs had been 311 previously exposed to a cAMP-mediated pre-IVM treatment of at least 2 hours ( Figure 3C ). By 312 12 h of culture no differences were observed among any groups, indicating that under these 313 conditions, the limit to CC-oocyte GJC is 12 h of IVM. 314 315
Effect of pre-IVM on the level of bovine intra-oocyte GSH content during IVM 316
The representative images of intra-oocyte MCB fluorescence at 0 h and 24 h of IVM, 317 indicative of GSH levels, are presented in Figure 4A . The duration of pre-IVM exposure to 318 FSK+IBMX significantly affected intra-oocyte GSH content, with levels at the end of pre-IVM 319 (0h IVM) significantly higher after 4 h or 6 h of pre-IVM, in comparison with 2 h and the control 320 (no pre-IVM) group ( Figure 4B; P<0.05 ). This pattern persisted after 24 h of IVM, where 321 intra-oocyte GSH was higher with increasing length of the pre-IVM period, with a significantly 322 (P<0.05) higher content observed in the 6 h pre-IVM group compared with the control. This 323 indicates that longer pre-IVM periods influence intra-oocyte GSH accumulation, not only 324 during the pre-IVM stages but also possibly throughout IVM. Based on this, we hypothesized 325 that GSH accumulation in the oocyte from pre-IVM treatment was due to the enhanced GJC. 326
327
Effect of inhibiting GJC on GSH accumulation 328
To assess the contribution of CC-oocyte GJC to intra-oocyte GSH levels following pre-IVM 329 13 treatment with FSK and IBMX, we treated COCs during pre-IVM with carbenoxolone (CBX), a 330 known gap junction inhibitor which we previously validated in bovine COCs (Thomas et al., 331 2004), and assessed LY dye transfer from the oocyte to the cumulus vestment and 332 intra-oocyte MCB fluorescence. CBX was effective at blocking CC-oocyte GJC (Figure 5A ; 333 P<0.01) at 4 h of culture in the presence of FSK and IBMX. The intra-oocyte GSH content was 334 significantly decreased ( Figure 5B ; P<0.05) by CBX in both control and FSK+IBMX treated 335 COCs. These results provide further evidence that CCs contribute to the accumulation of 336 GSH in the oocyte via a GJC-mediated mechanism and that intra-oocyte GSH levels are 337 enhanced by FSK and IBMX during the pre-IVM period. 338 339
Effect of inhibition of GSH synthesis on H2O2 production and embryonic development 340
As intra-oocyte GSH levels are regarded as important in managing reducing reactive oxygen 341 species (ROS) in the oocyte (Guerin et al., 2001) , we assessed the effect of depleted oocyte 342 GSH levels on H2O2 content of oocytes and their subsequent developmental capacity. We 343 depleted oocyte GSH levels by treating COCs with 10 mM buthionine sulfoximide (BSO) a 344 validated inhibitor of glutathione synthase (Sutovsky and Schatten 1997) . BSO treatment 345 ablated the pre-IVM (FSK+IBMX)-induced increase in intra-oocyte GSH ( Figure 6C ; P<0.05). 346 H2O2 production in the oocyte was evaluated with PF-1 staining ( Figure 6A ; (Purdey et al., 347 2015) ). Pre-IVM with FSK+IBMX significantly decreased intra-oocyte H2O2 levels (Figures 348 6A(b) and 6B), but this response was eliminated with BSO treatment, suggesting that 349 reduction of GSH levels coincides with an increase in H2O2 production in oocytes. Here we report that increasing the length of pre-IVM treatment with FSK and IBMX positively 361 impacts GJC in bovine COCs, which in turn increases intra-oocyte GSH and lowers 362 intra-oocyte H2O2, establishing a mechanism contributing to the improved oocyte 363 developmental competence observed following pre-IVM in the presence of cAMP modulators. 364
The use of cAMP modulators during pre-IVM and/or IVM, to provide a high intracellular cAMP 365 levels within CCs and the oocyte, is associated with prolonged CC-oocyte GJC (Luciano et al., 366 2004; Shu et al., 2008; Albuz et al., 2010; Franciosi 367 et al., 2014) , in addition to the inhibition, or at least a delay, in the timing of germinal vesicle 368 breakdown (GVBD). The resumption and completion of meiosis is particularly delayed when 369 cAMP modulating agents (FSK + IBMX) are present during pre-IVM stage and combined with 370 cilostamide, a PDE3 inhibitor, during the IVM phase, as per the 'simulated physiological 371 oocyte maturation' (SPOM) version 1 system (Albuz et al., 2010) . Further work showed that 372 the beneficial impact of the SPOM system may lie specifically in the pre-IVM period (Zeng et 373 al., 2013; Richani et al., 2014; Zeng et al., 2014) , which led to the concept of SPOM version 2 374 (SPOMv2), wherein there is an absence of cAMP modulators during IVM (Gilchrist et al., 375 2015), and is the system used in the current study. Numerous mechanisms have been 376 identified as contributing to enhanced developmental competence following SPOMv2, such 377 as enhanced COC oxygen consumption and oocyte oxidative metabolism (Zeng et al., 2013; 378 Richani et al., 2014; Zeng et al., 2014) and accentuating epidermal growth factor (EGF) 379 signaling in CCs (Zeng et al., 2013; Richani et al., 2014; Zeng et al., 2014) . Here we add to 380 these concepts by revealing that extending the pre-IVM period for up to 6 hours further 381 enhances oocyte developmental competence, most likely by increasing the oocyte's 382 anti-oxidant defence and decreasing ROS levels. 383
384
The pre-ovulatory gonadotrophin surge leads to a transient increase of cAMP in the somatic 385 compartment of the follicle, including in CCs (Tsafriri et al., 1972; Yoshimura et al., 1992; 386 Mattioli et al., 1994; Albuz et al., 2010) , but a simultaneous fall in intra-oocyte cGMP and 387 cAMP (Norris et al., 2009 ). This cAMP surge in the COC is typically impaired or absent using 388 standard clinical IVM protocols, with likely deleterious consequences for oocyte 389 15 developmental competence, which is the impetus for developing cAMP-modulated IVM 390 systems (Gilchrist 2011) . Such IVM systems typically use a pre-IVM phase containing cAMP 391 elevating agents; COCs are commonly exposed to cAMP modulators for 0.25 -2 hours prior 392 to IVM (Luciano et al., 1999; Guixue et al., 2001; Albuz et al., 2010) , but this can be up to 20 393 hours, for example using porcine oocytes (Funahashi et al., 1997) coinciding with GVBD in 394 that species. 395 396 While the beneficial effects of cAMP modulated pre-IVM on oocyte competence are well 397 accepted, the optimal duration of pre-IVM is largely unknown. A recent study shows extending 398 pre-IVM exposure to cAMP modulators beyond 1-2h appears beneficial to mouse oocyte 399 quality (Richani et al., 2014) . In this study we investigated the effect of 0, 2, 4 and 6 hours of 400 pre-IVM with FSK + IBMX followed by standard IVM on subsequent embryo development. 401
Consistent with previous studies using a 2 hour pre-IVM system, all pre-IVM durations 402 examined here led to notable improvements in subsequent embryo development and quality, 403 compared to standard IVM. The 6 h pre-IVM treatment had an optimal effect on oocyte 404 development competence, as reflected in the fastest rate of 2-cell embryo formation, the 405 highest yield of hatched blastocysts and notably the highest ratio of ICM to total cells among 406 all treatments. It has previously been shown that rapid cleave of bovine embryos is a strong 407 predictor of embryo quality and pregnancy success, as assessed by embryo karyotyping, 408 expression of interferon tau and pregnancy rates (Sugimura et al., 2012) . In addition, in an 409 IVM context, it is common to see the effects of treatments that improve oocyte quality having 410 little or no effect on MII and total cleavage rates, but manifesting in increased blastocyst rates 411 and ICM cell numbers, both of which are associated with improved implantation and fetal 412 survival rates (Albuz et al., 2010; Sudiman et al., 2014) . 413
414
One complication of using a cAMP modulated IVM system and altering the pre-IVM interval is 415 the effect on oocyte meiotic kinetics (Gilchrist et al., 2015) , which is compounded by the fact 416 that FSK acts initially as an inhibitor and then an inducer of meiosis (Dekel et al., 1988; 417 Yoshimura et al., 1992) . Hence, we examined the time required to reach MII using the 418 16 different pre-IVM durations with the consequence that, with a 6 hour pre-IVM internal, the IVM 419 phase was shortened to 20 hours (total of 26 hours). 420
421
In the current study, pre-IVM with FSK+IBMX fully sustained GJC functionality in COCs 422 throughout the 6 hours examined, in notable contrast to the loss of GJC that occurred in 423 untreated COCs. Furthermore, the effect of pre-IVM on GJC persisted a further 8 hours into 424 the IVM phase. Hence, in the pre-IVM 6h group, GJC was higher than in control COCs for a 425 total of 14 hours. Stimulation of CC cAMP synthesis by FSK or gonadotrophins enhances 426 Cx43 (connexin 43) expression and stimulates phosphorylation of Cx43 at specific residues, 427 possibly via a protein kinase A-dependent mechanism, collectively sustaining GJC 428 functionality (Granot and Dekel 1994; Yogo et al., 2006; Sasseville et al., 429 2009). The use of FSH in conjunction with PDE inhibitors or natriuretic peptide precursor 430 (NPPC), which leads to oocyte PDE inhibition, also sustains CC-oocyte GJC (Thomas et al., 431 2004; Franciosi et al., 2014) . In the current study, the sustained somatic cell support to the 432 oocyte through at least half of oocyte maturation is likely to be a key factor in the enhanced 433 quality of subsequent oocytes (Gilchrist and Richani 2013) . One proposed benefit of CC 434 support is the ordered cessation of oocyte transcription and appropriate remodeling of 435 chromatin in preparation for meiosis (Luciano et al., 2011; Franciosi et al., 2014) . Another 436 benefit of extended CC-oocyte GJC is increased accumulation of beneficial CC nutrients and 437 metabolites in the oocyte, such as glutathione . and scored as 2, 1, 0, respectively, and the gap junction index calculated. A total of 690 oocytes were used in these experiments (3 replicates per group). B: COCs were treated with or without FSK + IBMX in pre-IVM and GJC was assessed at 0, 2, 4 or 6 h. "a" represents the 29 lack of difference between time points within the FSK+IBMX treatment. Means with non-common letters (x, y, z) are significantly different (P<0.05; 1-way ANOVA) between time points within the control treatment. Asterisks indicate means that are significantly different (P<0.05; t-test) between pre-IVM treatments at that time point. C: COCs were treated with or without FSK + IBMX in pre-IVM for 2, 4 or 6 h, and then cultured in IVM with FSH and then GJC was assessed at 0, 4, 8 or 12 h of IVM. Means with no common superscript letters "a-b,
x-y, p-q" within a time point are significantly different (P<0.05; 2-way ANOVA). 
